GERMANY – Evonik, one of the world leaders in specialty chemicals, unveiled that it will launch its new generation Biolys®, which provides a higher concentration of L-lysine, for animal feeds on June 1, 2023, Feed and Additives has reported.
With a presence in more than 100 countries globally, Evonik said that the move is envisioned in keeping with the tradition of supplying the market with innovative products and solutions to benefit its customers.
According to the company, the new generation Biolys® is produced at Evonik’s sites in Castro, Paraná, Brazil, and Blair, Nebraska, USA, serving mainly the markets in the Americas, but also in the Middle East and Africa packed in its traditional packaging versions.
The new Biolys® formulation contains 62.4 percent L-lysine (an 80 percent ratio to Lysine HCl) compared to the current version’s 60 percent L-lysine (a 77 percent ratio to Lysine HCl).
The product also contains valuable components resulting from its fermentation process, additional nutrients, and energy that further benefit livestock such as swine or poultry.
Dr. Martin Steffan, product manager of Biolys® at Evonik Animal Nutrition said that the new Biolys® allows customers to meet their animals’ requirements for the essential amino acid L-lysine even more efficiently, adding that they can achieve the usual effect with less product.
This is fully in line with our strategy to meet growing global demand for high-quality animal protein for healthy human nutrition using a minimum of natural resources,” he stressed.
The innovative product, Biolys® is produced through fermentation. Microorganisms convert dextrose, a sugar derived from corn, into L-lysine resulting in a product containing L-lysine granulated with a nutritionally rich biomass.
Recently, the company invested €25M (US$27.3M) in developing and expanding its methyl mercapto-propionaldehyde (MMP) production plant, an organic compound that is integral in the production of DL-methionine in a move to strengthen its world-scale global methionine production network
According to Dr. Gaetano Blanda, head of the Animal Nutrition business line, the investment will enable Evonik to strengthen the European methionine network and safeguard its long-term supply of MMP to its MetAMINO production hub in Antwerp, Belgium.
“The move underscores our commitment to serving and expanding the global DL-methionine market and secures the best possible supply security for our customers,” Gaetano added.
In addition, Evonik prides that Since 2021, the company has managed to reduce the CO2 emissions from this production process by roughly 20 percent, leading to the lowest carbon footprint for lysine available on the market.